Takeda Digital Ventures

Amwell provides payers and healthcare systems with a single technology-based care platform, improving access to care across the continuum through virtual and automated care solutions.

Oshi Health provides virtual, whole-person gastrointestinal (GI) health care, focusing on diagnosing and treating a wide range of digestive issues through a personalized approach.

ISHI Health is revolutionizing heart failure and complex cardiac care through innovative technology and AI-driven insights, providing personalized care and improving patient outcomes.

Maia Oncology is the first virtual comprehensive primary care clinic for cancer patients and survivors, focusing on managing the long-term complications and toxicities that arise from cancer treatment.

An integrative rheumatology practice focused on whole person care for autoimmune conditions, combining rheumatology with lifestyle medicine to improve patient outcomes.

aptihealth is transforming behavioral healthcare by providing integrated access to personalized mental health services for individuals of all ages, ensuring timely and effective care through innovative technology and a multidisciplinary care team.

Tele911 connects EMS with Board-Certified Emergency Medicine physicians in real time, providing immediate assistance and support to patients while reducing unnecessary emergency room visits.

Boulder Care offers telehealth addiction treatment grounded in kindness, respect, and unconditional support. Their program is designed by addiction medicine specialists and people with lived experience of recovery, focusing on improving the lives of individuals with substance use disorders through a comprehensive, evidence-based approach.

Aspen RxHealth is transforming how healthcare organizations deliver clinical pharmacy services by connecting them with tools, technology, and a nationwide pharmacist community to improve medication management and patient outcomes.

Small specialist team of physicians and operator-investors in a pharma–VC joint venture, focused exclusively on personalized medicine, data analytics and clinically validated digital therapeutics, with early DTx track record. DigiTx Partners is a venture capital fund launched as a joint venture between global pharma company Astellas Pharma and life-sciences VC MPM Capital, exclusively focused on digital health investments around three specific pillars: Personalized Medicine, Data Analytics, and Digital Therapeutics. The fund operates as a small specialist team combining physicians and operators with investing backgrounds, known for being early investors in prescription and clinically validated digital therapeutics.

Evergreen, patient structure enables flexible checks and long holds for early-stage healthcare companies (>$1M ARR), combining deep sector expertise, VC, PE and real estate platform plus cash-yielding kiosks.

Define Ventures runs a free AI Fellows program connecting founders to former Fortune 100 health CEOs, tailored go-to-market training, enduring partner mentorship, and network of payers, providers, employers, and life-science companies.

Mid-growth digital health investor offering concentrated capital to about a dozen companies, partners with seven prior exits totaling $4B+, Latin American pharma heritage and tri-continental market access.

Pre-seed and early-stage investor backing underrepresented founders building health-equity tools for marginalized communities. Operating as the pre-seed arm within Seae Ventures platform under Managing Director Erica Murdock, an experienced healthcare operator. Originally founded by the late Kayode Owens.